Cargando…
Daptomycin approved in Japan for the treatment of methicillin-resistant Staphylococcus aureus
Daptomycin is a lipoglycopeptide antibacterial drug that is rapidly bactericidal for methicillin-resistant Staphylococcus aureus (MRSA) infection and has antibiotic activity against a wide range of Gram-positive organisms. It has been approved by the Ministry of Health, Labor and Welfare in Japan fo...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3284219/ https://www.ncbi.nlm.nih.gov/pubmed/22368449 http://dx.doi.org/10.2147/TCRM.S23875 |